entertainment -WSS

entertainment

author：leisure time 2025-08-11 11:44:09 - browse：5225

Marc Tessier Lavigne (center) retracted two Science papers on the day his resignation as Stanford president takes effect. Mattarella in San Francisco

After an expansive investigation found manipulated data and other issues with papers co-authored by Stanford’s now ex-president Marc Tessier-Lavigne, the prominent neuroscientist on Thursday retracted two studies published in the journal Science in 2001 — over the objection of a former postdoctoral researcher who played a leading role in both projects.

The retractions come the same day that Tessier-Lavigne’s resignation as Stanford president takes effect. His departure was prompted by a 95-page report released by a special committee of the university’s Board of Trustees, which recruited outside scientists and a former federal judge to investigate a dozen papers Tessier-Lavigne co-authored between 1999 and 2009, years before becoming the university’s leader.

The panel concluded that he did not personally engage in scientific misconduct, but it uncovered manipulated data in some studies Tessier-Lavigne had supervised and found that he took insufficient steps to “decisively and forthrightly” correct these studies.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Heart attack and stroke risk calculators need revising
Next article： Congress may force more Covid

hotspot

focus

WSS

How a Boston hospital is priming medical residents to use GPT

Readout Newsletter: Sarepta, Alnylam, and Royalty Pharma

New study raises questions about niacin and heart health

5 dead in mass shooting on Caribbean island of St. Vincent: Police

FDA panel unanimously endorses Eisai’s Alzheimer’s drug Leqembi

Judge denies Trump's request for new trial in E. Jean Carroll case

explore

entertainment

Wikipedia

Trump demands the U.S. pay no more for drugs than other countries … again

As AI regulations shape up, health tech startups beg for clarity

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Sanders wants to replace patents with prizes for drug inventions

Duchenne breakthrough therapy leaves behind pioneering families

Medicare Advantage enrollment grows 7.1% to 33.4 million people

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Delta passengers in Vegas fall sick while waiting on flight in triple

Duchenne breakthrough therapy leaves behind pioneering families

As AI regulations shape up, health tech startups beg for clarity

knowledge

New CMS data security rules will hurt Medicare, Medicaid research

Judge denies Trump's request for new trial in E. Jean Carroll case

Sanders wants to replace patents with prizes for drug inventions

Elevance, SCAN deals highlight health insurer acquisition scrutiny

FDA panel unanimously endorses Eisai’s Alzheimer’s drug Leqembi

This biotech could one day make human eggs from scratch. But first, they’re trying to rethink IVF

focus

hotspot

focus

leisure time